Laura Palmeri

Laura Palmeri

Ospedale Niguarda Ca' Granda, Milan - Milano / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4984875
person_outline Laura Palmeri's MOST POPULAR ARTICLES
1-) Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ... The Lancet Oncology 17 (6), 738-746, 2016 7952016
2-) Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)A Drilon, S Siena, SHI Ou, M Patel, MJ Ahn, J Lee, TM Bauer, AF Farago, ...Cancer discovery 7 (4), 400-409, 20177032017
3-) Sensitivity to entrectinib associated with a novel LMNA-NTRK1 gene fusion in metastatic colorectal cancer A Sartore-Bianchi, E Ardini, R Bosotti, A Amatu, E Valtorta, A Somaschini, ... JNCI: Journal of the National Cancer Institute 108 (1), 2016 1402016
4-) Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: systematic review of different strategiesG Mauri, EG Pizzutilo, A Amatu, K Bencardino, L Palmeri, EF Bonazzina, ...Cancer treatment reviews 73, 41-53, 2019
5-) Regulatory cytokine gene polymorphisms and risk of colorectal carcinomaA Crivello, A Giacalone, M Vaglica, L Scola, GI Forte, MC Macaluso, ...Annals of the New York Academy of Sciences 1089 (1), 98-103, 2006